Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Global Business Websites |
     
  3. Contact us |
  4. Sitemap |
  5. Help
  1. Font size

    Reduce the font size Increase the font size  
 
 

Central Nervous System

Contact us

Sanofi in Egypt

3, El Massaneh St.
Zietoun, Cairo, Egypt
P.O. 1486

Tel.: +202 22860000 - 22860060/1/2
Fax: +202 2282906 - 22824855

Content :

Central Nervous System

Since the human neuronal system is extremely complex most of the disease affecting the central nervous system (CNS) do not receive optimal treatment with currently available therapies.

 

A cluster of complex diseases

Some of these conditions are:

  • Alzheimer’s disease: a neurodegenerative pathology which progressively impairs cognitive ability, and brings about behavioral disorders and functional deterioration leading to dementia, 
  • Multiple Sclerosis (MS): characterized by destruction of the myelin, which covers and protects the nerves of the central nervous system, 
  • Schizophrenia: generally a chronic disease marked by delirium, hallucinations or introspection and inability to act,  
  • and also InsomniaAnxietyParkinson’s disease.

These are major public health issues

Approximately 22 million patients suffer from various forms of dementia, two thirds of which are related to Alzheimer’s. Prevalence of this disease could double within the next 25years. The WHO (World Health Organization) estimates the number of people suffering from multiple sclerosis worldwide at 2.5 million. As for schizophrenia, 1% of the world’s population may be at risk.

Epilepsy

Epilepsy is the most common serious neurological disorder. Children under 10 and old people are particularly vulnerable.

It is characterized by repeated spontaneous seizures caused by an excessive discharge of neurons in the brain. Seizures themselves can lead to injury, and the condition often results in a profound loss of self-confidence.

However, with good counseling and treatment (including new techniques of functional cerebral imaging as well as drugs that reduce the incidence of seizures), the vast majority of patients can live normal productive and fulfilling lives.

Bipolar disorder

Is a mental illness classified by psychiatry as a mood disorder. Individuals with bipolar disorder experience episodes of a very high mood known as mania alternating with episodes of depression.

Mania can occur with different levels of severity. Individuals who experience manic episodes also commonly experience depressive episodes; some experience a mixed state in which features of both mania and depression are present at the same time. Manic and depressive episodes last from a few days to several months.

About 4% of people suffer from bipolar disorder. Prevalence is similar in men and women and, broadly, across different cultures and ethnic groups. Genetic factors contribute substantially to the likelihood of developing bipolar disorder, and environmental factors are also implicated.

Updated March 02, 2015